A multicenter phase II trial of carboplatin and cetuximab for treatment of advanced nonsmall cell lung cancer.
A multicenter phase II trial of carboplatin and cetuximab for treatment of advanced nonsmall cell lung cancer. Cancer Invest. 2010 Feb; 28(2):208-15.